Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis

Andrology

Volumn 2, Issue 3, 2014, Pages 421-427

  Overvad, S ^a   Bay, K ^b   Bojesen, A ^c   Gravholt, C H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Body composition; Hypogonadism; Hypothalamus pituitary testicular bone axis; Leydig cell function; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN LIKE FACTOR 3; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; MESTEROLONE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE HORMONE; SEX HORMONE BINDING PROTEIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D; CELL SURFACE RECEPTOR; GLUCOSE BLOOD LEVEL; LEYDIG INSULIN-LIKE PROTEIN; LIPID; PROTEIN; SEX HORMONE-BINDING GLOBULIN RECEPTOR;

ADULT; AGE DISTRIBUTION; ANDROGEN THERAPY; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE METABOLISM; CAG REPEAT; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GYNECOMASTIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN BLOOD LEVEL; KLINEFELTER SYNDROME; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TESTIS SIZE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ANALYSIS; BLOOD; BONE; CLINICAL TRIAL; GLYCEMIC INDEX; HORMONE SUBSTITUTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BONE AND BONES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FOLLICLE STIMULATING HORMONE; GLYCEMIC INDEX; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; KLINEFELTER SYNDROME; LIPIDS; LUTEINIZING HORMONE; MALE; METABOLIC SYNDROME X; OSTEOCALCIN; PROTEINS; RECEPTORS, CELL SURFACE; TESTOSTERONE;

EID: 84899093763     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/j.2047-2927.2014.00204.x     Document Type: Article

References (33)

1. Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N et al. (2005) Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 90, 3410-3418.
2. Bay K, Matthiesson KL, McLachlan RI & Andersson AM. (2006) The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. J Clin Endocrinol Metab 91, 1108-1111.
3. Bojesen A, Juul S & Gravholt CH. (2003) Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 88, 622-626.
4. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P et al. (2006) The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29, 1591-1598.
5. Bojesen A, Birkebæk N, Kristensen K, Heickendorff L, Mosekilde L, Christiansen JS et al. (2011a) Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 22, 1441-1450.
6. Bojesen A, Hertz JM & Gravholt CH. (2011b) Genotype and phenotype in Klinefelter syndrome - impact of androgen receptor polymorphism and skewed X inactivation. Int J Androl 34, e642-e648.
7. Cabrol S, Ross JL, Fennoy I, Bouvattier C, Roger M & Lahlou N. (2011) Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels. J Clin Endocrinol Metab 96, E746-E753.
8. Confavreux CB. (2011) Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int 79 (Suppl. 121), S14-S19.
9. Ermetici F, Donadio F, Iorio L, Malavazos AE, Dolci A, Peverelli E et al. (2009) Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function. Eur J Endocrinol 161, 853-859.
10. Ferlin A, Pepe A, Gianesello L, Garolla A, Feng S, Giannini S et al. (2008) Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Miner Res 23, 683-693.
11. Ferlin A, Perilli L, Gianesello L, Taglialavoro G & Foresta C. (2011a) Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts. PLoS ONE 6, e29733.
12. Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di Mambro A, Selice R et al. (2011b) Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96, E739-E745.
13. Ferlin A, Schipilliti M & Foresta C. (2011c) Bone density and risk of osteoporosis in Klinefelter syndrome. Acta Paediatr 100, 878-884.
14. Ferlin A, Selice R, Carraro U & Foresta C. (2013) Testicular function and bone metabolism-beyond testosterone. Nat Rev Endocrinol 9, 548-554.
15. Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF et al. (2013) Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 369, 1011-1022.
16. Foresta C, Di Mambro A, Pagano C, Garolla A, Vettor R & Ferlin A. (2009) Insulin-like factor 3 as a marker of testicular function in obese men. Clin Endocrinol (Oxf) 71, 722-726.
17. Hejazi K & Hosseini SR. (2012) Influence of selected exercise on serum immunoglobulin, testosterone and cortisol in semi-endurance elite runners. Asian J Sports Med 3, 185-192.
18. Hirsch HJ, Eldar-Geva T, Gross-Tsur V, Benarroch F, Roger M & Lahlou N. (2013) Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy through adulthood. J Clin Endocrinol Metab 98, E135-E143.
19. Ivell R & Anand-Ivell R. (2011) Biological role and clinical significance of insulin-like peptide 3. Curr Opin Endocrinol Diabetes Obes 18, 210-216.
20. Ivell R, Wade JD & Anand-Ivell R. (2013) INSL3 as a biomarker of Leydig cell functionality. Biol Reprod 88, 1-8.
21. Jensen MB. (2014) Vitamin D and male reproduction. Nat Rev Endocrinol 10, 175-186.
22. Lanfranco F, Kamischke A, Zitzmann M & Nieschlag E. (2004) Klinefelter's syndrome. Lancet 364, 273-283.
23. Lee DM, Tajar A, Pye SR, Boonen S, Vanderschueren D, Bouillon R et al.; EMAS study group. (2012) Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol 166, 77-85.
24. Nielsen J & Wohlert M. (1990) Sex chromosome abnormalities found among 34, 910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser 26, 209-223.
25. Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, Haug E et al. (2007) Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab 92, 2696-2705.
26. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE et al. (2011) Endocrine regulation of male fertility by the skeleton. Cell 144, 796-809.
27. Pilz S, Frisch S, Koertke H, Kuhn J, Dreier J, Obermayer-Pietsch B et al. (2011) Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 43, 223-225.
28. Roth MY, Lin K, Bay K, Amory JK, Anawalt BD, Matsumoto AM et al. (2013) Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. Fertil Steril 99, 132-139.
29. Schwetz V, Pieber T & Obermayer-Pietsch B. (2012) The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol 166, 959-967.
30. Smyth CM & Bremner WJ. (1998) Klinefelter syndrome. Arch Intern Med 158, 1309-1314.
31. Tchernof A & Després JP. (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93, 359-404.
32. Thomsen HH, Møller HJ, Trolle C, Groth KA, Skakkebæk A, Bojesen A et al. (2013) The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids. Endocr Connect 2, 216-224.
33. Trabado S ML, Maione L, Bry-Gauillard H, Affres H, Salenave S, Sarfati J et al. (2014) Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients. J Clin Endocrinol Metab 99, E268-E275.